CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 132 enrolled
Drug / intervention
silicone geldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03601247
NCT03601247N/ACompleted
CompareCT.gov

Efficacy of Silicone Gel Versus Placebo for Postsurgical Scars of the Eyelid

Montefiore Medical Center·interventional·Posted Jul 26, 2018·Updated Feb 17, 2026

In Brief

A clinical study evaluating silicone gel for Scarring Due to Treatment. Completed, enrolled 132 participants across 1 site.

Detailed Summary

To determine whether silicone gel is effective at preventing or minimizing scar formation after eyelid surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsScarring Due to Treatment
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 26, 2018
Enrollment StartAug 1, 2018
Primary CompletionJan 11, 2024
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 7.9 years ago

Interventions

silicone geldevice

Patients who have consented to the study will receive two tubes labeled only "left" and "right", corresponding to the side of the face to which the tube contents will be applied. One tube will contain silicone gel and the other tube will contain aquaphor. Neither the patient nor the surgeon will know what side will receive which treatment. These tubes will be given to patients at post-operative week 1 visit. Patients will be instructed to rub the solution into their eyelid incisions gently with their fingers for 2-3 minutes twice a day